1. 2015
  2. The Hippo pathway effector YAP controls mouse hepatic stellate cell activation

    Mannaerts, I., Leite, S. B., Verhulst, S., Claerhout, S., Eysackers, N., Thoen, L. F. R., Hoorens, A., Reynaert, H., Halder, G. & van Grunsven, L. A., Sep 2015, In : Journal of Hepatology. 63, 3, p. 679-688 10 p.

    Research output: Contribution to journalArticleResearchpeer-review

  3. Distal intestinal obstruction in CF patients

    Maus, J., Mana, F., Reynaert, H. & Urbain, D., 30 Jun 2015, In : Acta Gastro-Enterologica Belgica. 78, 1, p. 49-52 4 p.

    Research output: Contribution to journalArticleResearchpeer-review

  4. Impact of intensive enteral nutrition in association with corticosteroids in the treatment of severe alcoholic hepatitis: a multicenter randomized controlled trial.

    Reynaert, H., 2015, In : Acta Gastro-Enterol Belg. 78, 1, p. A01 1 p.

    Research output: Contribution to journalMeeting abstract (Journal)Research

  5. Paritaprevir/Ritonavir, Ombitasvir and Dasabuvir with or without Ribavirin achieves 98,6% sustained virologic response in Belgian GT1 infected patients.

    Reynaert, H., 2015, In : Acta Gastro-Enterol Belg. 78, 1, p. A21 1 p.

    Research output: Contribution to journalMeeting abstract (Journal)Research

  6. Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II)

    Zeuzem, S., Flisiak, R., Vierling, J. M., Mazur, W., Mazzella, G., Thongsawat, S., Abdurakhmanov, D., Van Kính, N., Calistru, P., Heo, J., Stanciu, C., Gould, M., Makara, M., Hsu, S-J., Buggisch, P., Samuel, D., Mutimer, D., Nault, B., Merz, M., Bao, W. & 5 othersGriffel, L. H., Brass, C., Naoumov, N. V., ESSENTIAL II Study Group (with Hendrik Reynaert) & Reynaert, H., 2015, In : Alimentary Pharmacology & Therapeutics. 42, 7, p. 829-844 16 p.

    Research output: Contribution to journalArticleResearchpeer-review

  7. 2014
  8. Impact of intensive enteral nutrition in association with corticosteroids in the treatment of severe alcoholic hepatitis: a multicenter randomized controlled trial

    Reynaert, H., Oct 2014, In : Hepatology. 60, S1, p. 269A

    Research output: Contribution to journalMeeting abstract (Journal)Research

  9. SVR12 Rate of 95.7% in 209 HCV Genotype 1-Infected Null Responders Treated With ABT-450/r/Ombistarvir and Dasabuvir With or Without Ribavirin

    Reynaert, H., Oct 2014, In : Hepatology. 60, S1, p. 1133A

    Research output: Contribution to journalMeeting abstract (Journal)Research

  10. Syncoilin is an intermediate filament protein in activated hepatic stellate cells.

    Van Rossen, E., Liu, Z., Blyweert, D., Eysackers, N., Mannaerts, I., Schroyen, B., El Taghdouini, A., Reynaert, H. & Van Grunsven, L., Jan 2014, In : Histochemistry and Cell Biology. 141, 1, p. 85-99 15 p.

    Research output: Contribution to journalArticleResearchpeer-review

  11. Characteristics, treatment, and virologic responses of chronic hepatitis C patients treated with peginterferon alfa-2a and ribavirin in belgium: a sub-analysis of the PROPHESYS study

    Mulkay, J. P., Bourgeois, S., Lasser, L., De Galocsy, C., Tomasovic, S., Horsmans, Y., Van Vlierberghe, H., Reynaert, H. & Belgian PROPHESYS investigators, 2014, In : Acta Gastro-Enterologica Belgica. 77, 1, p. 30-40 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

  12. SVR12 Rate of 98.6% in 992 HCV Genotype 1b-Infected Patients Treated with ABT-450/r/Ombitasvir and Dasabuvir With or Without Ribavirin

    Colombo, M., Weiland, O., Cohen, D. E., DuFour, J-F. J., Reynaert, H., Diago, M., Villa, E., Streinu-Cercel, A., Xie, W., Baykal, T., Enejosa, J., Coakley, E., Trinh, R. & Podsadecki, T., 2014, In : Hepatology. 60, p. 1131A-1131A

    Research output: Contribution to journalMeeting abstract (Journal)Research

Previous 1 2 3 4 5 6 7 8 ...25 Next

ID: 33804